European Companies Search Engine
Alexion Pharmaceuticals Inc., Boston, United States
Watch
If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.
Dossier
The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .
Add to dossier (if available):
Name
Alexion Pharmaceuticals Inc.
Alexion Pharmaceuticals
Acetylon Pharmaceuticals Inc.
UDEC Pharmaceuticals Inc.
Identification
Address
Corporate purpose
2834
Pharmaceutical Preparations
Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. The company offers ULTOMIRIS (ALXN1210/ravulizumab-cwvz), a C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS); and SOLIRIS (eculizumab), a monoclonal antibody for the treatment of PNH, aHUS, generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD) … Show more
History
Network
Loading network
Publications
Year 2025
in
Epobase
11 Jan 2025
as
Alexion Pharmaceuticals
Year 2024
in
Epobase
16 Aug 2024
13 Aug 2024
Year 2021
in
Epobase
30 Jul 2021
30 Jul 2021
26 May 2021
Year 2019
in
Epobase
Year 2018
in
Euipotm
Year 2017
in
Epobase
6 Oct 2017
11 Aug 2017
21 Feb 2017
via
Alexion Pharma Germany GmbH
also
27/04/2016
Year 2016
in
Euipotm
Year 2015
in
Epobase
2 Dec 2015
15 Apr 2015
17 Mar 2015
24 Oct 2014
21 Mar 2014
20 May 2013
Year 2012
in
Epobase
Year 2008
in
Epobase
19 Aug 2008
22 May 2008
4 Apr 2008
Year 2007
in
Epobase
There are no publications matching your search.
Mentions
12 Oct 2024
in
Psc
There are no publications matching your search.
The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.
The visualizations for "Alexion Pharmaceuticals Inc., Boston, United States"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
